Both in Pharmaceuticals
Trevi Therapeutics vs Nektar Therapeutics
Over the past year TRVI returned +61.1% and NKTR returned +0.5%; their daily moves had a correlation of 0.29.
TRVI +61.1% NKTR +0.5%Growth of $1, one year, split-adjusted
| Metric | TRVI | NKTR |
|---|---|---|
| Price | $14.42 | $59.24 |
| Market cap | $2.05B | $2.02B |
| Today | +0.14% | −1.92% |
| 1 month | −14.1% | −18.3% |
| 6 months | +28.9% | −9.2% |
| Year to date | +15.2% | +40.1% |
| 1 year | +64.4% | +1.3% |
| Revenue growth (YoY) | — | −9.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −401.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 37.1× |
| Net cash | $318.9M | $684.3M |
| Dividend yield | — | — |
| Volatility (60d) | 59.0% | 43.7% |
| Short % of float | 12.3% | 17.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).